H43.23

Clinical Causes: Age-related changes in the vitreous humor Increased levels of certain metabolic substances, such as cholesterol or lipids Deposits of calcium or other minerals High levels of homocysteine in the blood Diabetes mellitus, especially with diabetic retinopathy Ocular injuries or inflammation Certain hereditary eye conditions Previous eye surgeries or cataract operations Systemic diseases affecting connective tissue or mineral metabolism Chronic systemic conditions like hyperlipidemia

Key Symptoms: Minimal to no visual disturbance; often discovered incidentally Presence of small, shiny, crystalline spots floating in the visual field Vague shimmering or flashing sensations in some cases Possible perception of floaters, especially if deposits are sizable or numerous Rarely, if deposits interfere with the visual axis, leading to blurry vision

Diagnosis Path: Diagnosis is typically made during a comprehensive eye examination. The ophthalmologist uses slit-lamp biomicroscopy and indirect ophthalmoscopy to observe and identify crystalline deposits within the vitreous body. Additional tests may include optical coherence tomography (OCT) or ultrasound imaging if necessary to assess the vitreous and retina. Blood tests might be recommended to evaluate levels of lipids, calcium, or other metabolic markers that could contribute to the development of deposits.

Treatment Protocols: In most cases, crystalline deposits in the vitreous do not require treatment, especially if they do not impair vision. Regular eye examinations help monitor any changes over time. If deposits cause significant visual disturbance or are associated with underlying systemic conditions, managing the primary health issue is important. Rarely, if deposits lead to vitreous floaters that significantly disrupt vision, surgical options like vitrectomy may be considered, though these are typically reserved for severe cases. Addressing systemic factors such as lipid levels or metabolic imbalances can also help prevent further deposits.